{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T03:10:10Z","timestamp":1784257810751,"version":"3.55.0"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Drug reaction with eosinophilia and systemic symptoms (DRESS) is a severe systemic hypersensitivity drug reaction with diverse skin morphologies, including erythema multiforme (EM)-like lesions. Limited literature exists on the prognostic significance of EM-like lesions in patients with DRESS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To compare organ involvement and prognosis of patients with DRESS in those with EM-like lesions and those without EM-like lesions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a prospective case\u2013control study among patients with DRESS at a tertiary care centre in northern India comparing organ involvement and prognosis of those with EM-like lesions vs. a matched control population without EM-like lesions. Clinical records of 115 patients with DRESS enrolled in the study from January 2018 to August 2024 were reviewed. The diagnosis of DRESS was confirmed using European Registry of Severe Cutaneous Adverse Reactions (RegiSCAR) criteria. Based on the\u00a0RegiSCAR score, 72 patients with probable and definite DRESS were recruited and divided into two groups: those with EM-like lesions (cases, n = 25) and those without (controls, n = 47), matched by age, gender and race.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Patients with EM-like lesions had a significantly longer latency between drug intake and symptom onset (P = 0.007), a higher incidence of purpuric lesions (P &amp;lt; 0.001), a less common erythrodermic presentation (P = 0.034), greater palm and sole involvement (P = 0.003), facial oedema (P &amp;lt; 0.001) and mucosal involvement (P = 0.016), compared with controls. Those with EM-like lesions had a significantly elevated total leucocyte count (P = 0.028), higher C-reactive protein levels (P = 0.023), abnormal liver enzymes (alanine aminotransferase, aspartate aminotransferase) and lower eosinophil counts (P = 0.005), with a greater likelihood of hepatic involvement (odds ratio 6.9).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patients with DRESS with EM-like lesions experience a more severe disease course with greater hepatic involvement. The presence of these lesions could be used as a clinical marker for more aggressive disease necessitating multidisciplinary care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ced\/llag045","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T10:18:12Z","timestamp":1769422692000},"page":"1235-1240","source":"Crossref","is-referenced-by-count":1,"title":["Clinical and prognostic implications of erythema multiforme-like lesions in patients with drug reaction with eosinophilia and systemic symptoms: a prospective case\u2013control study"],"prefix":"10.1093","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6323-4988","authenticated-orcid":false,"given":"Keshavamurthy","family":"Vinay","sequence":"first","affiliation":[{"name":"Department of Dermatology, Venereology and Leprology, Post Graduate Institute of Medical Education and Research , Chandigarh ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2526-4494","authenticated-orcid":false,"given":"Sukhdeep","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Leprology, Post Graduate Institute of Medical Education and Research , Chandigarh ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajat","family":"Choudhary","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Leprology, Post Graduate Institute of Medical Education and Research , Chandigarh ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1165-1103","authenticated-orcid":false,"given":"Anuradha","family":"Bishnoi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Leprology, Post Graduate Institute of Medical Education and Research , Chandigarh ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0348-0815","authenticated-orcid":false,"given":"Davinder","family":"Parsad","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Leprology, Post Graduate Institute of Medical Education and Research , Chandigarh ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muthu Sendhil","family":"Kumaran","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Leprology, Post Graduate Institute of Medical Education and Research , Chandigarh ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"2026062510020281300_llag045-B1","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/ijd.17080","article-title":"A prospective observational study validating the CET score as a screening tool in suspected DRESS syndrome","volume":"63","author":"Singh","year":"2024","journal-title":"Int J Dermatol"},{"key":"2026062510020281300_llag045-B2","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jaad.2021.03.075","article-title":"Clinical, biochemical, and serologic predictors of drug reaction with eosinophilia and systemic symptoms syndrome: a prospective case\u2013control study","volume":"85","author":"Choudhary","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"2026062510020281300_llag045-B3","doi-asserted-by":"crossref","first-page":"722","DOI":"10.4103\/idoj.IDOJ_786_20","article-title":"Autoimmune diseases, end organ dysfunction and adverse drug reaction following drug reaction with eosinophilia and systemic symptoms (DRESS): a retrospective cohort study","volume":"12","author":"Sasidharanpillai","year":"2021","journal-title":"Indian Dermatol Online J"},{"key":"2026062510020281300_llag045-B4","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4103\/ijdvl.IJDVL_482_17","article-title":"Predictors of disease severity in drug reaction with eosinophilia and systemic symptoms","volume":"85","author":"Sasidharanpillai","year":"2019","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"2026062510020281300_llag045-B5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4103\/0378-6323.132249","article-title":"Drug reaction with eosinophilia and systemic symptoms: observations from a tertiary care institution","volume":"80","author":"Sasidharanpillai","year":"2014","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"2026062510020281300_llag045-B6","first-page":"347","article-title":"Current concepts on the diagnosis and pathogenesis of drug-induced hypersensitivity syndrome","volume":"52","author":"Shiohara","year":"2009","journal-title":"Jpn Med Assoc J"},{"key":"2026062510020281300_llag045-B7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/archderm.145.1.67","article-title":"Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure","volume":"145","author":"Eshki","year":"2009","journal-title":"Arch Dermatol"},{"key":"2026062510020281300_llag045-B8","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.jaad.2023.02.072","article-title":"Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis","volume":"90","author":"Wei","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"2026062510020281300_llag045-B9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jaad.2019.06.1309","article-title":"Dermatomyositis: clinical features and pathogenesis","volume":"82","author":"DeWane","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2026062510020281300_llag045-B10","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/bjd.12081","article-title":"Drug reaction with eosinophilia and systemic symptoms: is cutaneous phenotype a prognostic marker for outcome? A review of clinicopathological features of 27 cases","volume":"168","author":"Walsh","year":"2013","journal-title":"Br J Dermatol"},{"key":"2026062510020281300_llag045-B11","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/bjd.12501","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study","volume":"169","author":"Kardaun","year":"2013","journal-title":"Br J Dermatol"},{"key":"2026062510020281300_llag045-B12","doi-asserted-by":"crossref","first-page":"173.e1","DOI":"10.1016\/j.jaad.2013.05.003","article-title":"Toxic epidermal necrolysis: Part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis","volume":"69","author":"Schwartz","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"2026062510020281300_llag045-B13","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/106002809302700317","article-title":"Allopurinol hypersensitivity syndrome: a review","volume":"27","author":"Arellano","year":"1993","journal-title":"Ann Pharmacother"},{"key":"2026062510020281300_llag045-B14","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.1111\/jdv.17838","article-title":"Purpura as an indicator of severity in drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms: evidence from a 49-case series","volume":"36","author":"Takei","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026062510020281300_llag045-B15","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1111\/jdv.18100","article-title":"Skin manifestations and clinical features of drug reaction with eosinophilia and systemic symptoms: a retrospective multicentre study of 125 patients","volume":"36","author":"Lee","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026062510020281300_llag045-B16","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/jamadermatol.2024.1082","article-title":"Drug reaction with eosinophilia and systemic symptoms with pustulosis","volume":"160","author":"Hansen","year":"2024","journal-title":"JAMA Dermatol"},{"key":"2026062510020281300_llag045-B17","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1346-8138.2010.01086.x","article-title":"Possible association of vascular endothelial growth factor with the development of edema in drug-induced hypersensitivity syndrome","volume":"38","author":"Hirakawa","year":"2011","journal-title":"J Dermatol"},{"key":"2026062510020281300_llag045-B18","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jaad.2021.04.020","article-title":"Discriminating minor and major forms of drug reaction with eosinophilia and systemic symptoms: facial edema aligns to the severe phenotype","volume":"85","author":"Momen","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"2026062510020281300_llag045-B19","doi-asserted-by":"crossref","first-page":"e739","DOI":"10.1111\/jdv.18270","article-title":"Oblique earlobe crease as a novel physical examination finding in drug reaction with eosinophilia and systemic symptoms: a retrospective study","volume":"36","author":"Gilkey","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llag045\/66593882\/llag045.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/51\/7\/1235\/66593882\/llag045.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/51\/7\/1235\/66593882\/llag045.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T14:02:12Z","timestamp":1782396132000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/51\/7\/1235\/8442814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":19,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,1,28]]},"published-print":{"date-parts":[[2026,6,25]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llag045","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,1,28]]}}}